Classics in Chemical Neuroscience: Memantine | ACS Chemical Neuroscience
Derivatives of (R)-3-(5-Furanyl)carboxamido-2-aminopropanoic Acid as Potent NMDA Receptor Glycine Site Agonists with GluN2 Subunit-Specific Activity | Journal of Medicinal Chemistry
Neurodevelopmental Animal Models Reveal the Convergent Role of Neurotransmitter Systems, Inflammation, and Oxidative Stress as Biomarkers of Schizophrenia: Implications for Novel Drug Development | ACS Chemical Neuroscience
Derivatives of (R)-3-(5-Furanyl)carboxamido-2-aminopropanoic Acid as Potent NMDA Receptor Glycine Site Agonists with GluN2 Subunit-Specific Activity | Journal of Medicinal Chemistry
Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer's disease | Molecular Neurodegeneration | Full Text
Alzheimer's disease therapeutics: current strategies and future directions - ScienceDirect
Downstream Allosteric Modulation of NMDA Receptors by 3-Benzazepine Derivatives | Molecular Neurobiology
How does dopamine signalling at D1/D2/D4 receptors act on AMPA and NMDA? - Quora
PDF) N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer's Disease, Vascular Dementia and Parkinson's Disease
Grin2b knockdown in glutamatergic neurons blocks the effect of NYX-783... | Download Scientific Diagram
Figure presents a schematic model that summarizes the proposed theory... | Download Scientific Diagram
How could N-Methyl-D-Aspartate Receptor Antagonists Lead to Excitation Instead of Inhibition? - Tonghui Su, Yi Lu, Yang Geng, Wei Lu, Yelin Chen, 2018
Marked Prevention of Ischemic Brain Injury by Neu2000, an NMDA Antagonist and Antioxidant Derived from Aspirin and Sulfasalazine - Byoung Joo Gwag, Young Ae Lee, Sun Young Ko, Moon Jung Lee, Doo
Biomedicines | Free Full-Text | Pharmacological Potential of 3-Benzazepines in NMDAR-Linked Pathophysiological Processes
Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer's disease | Molecular Neurodegeneration | Full Text
Ketamine in neuropsychiatric disorders: an update | Neuropsychopharmacology